The unbinding studies of vascular endothelial growth factor receptor-2 protein tyrosine kinase type II inhibitors

•We used the method of drug design based on the fragment-build method.•Traditional MD simulations were used to obtain the stable conformation.•SMD simulation were conducted to identify which path is the favorable unbinding path.•SMD simulation along with the two directions of the pocket were performed.

Vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase has two conformations, active and inactive conformations. Type II inhibitors bind to inactive conformation. It has two possible binding/unbinding paths. To explore the unbinding path of inhibitor 01-435 that was generated by fragment build in the binding pocket of VEGFR-2, molecular dynamics (MD) simulation was performed on the crystal structure of VEGFR-2 in complex with 01-435, then steered molecular dynamics (SMD) simulation was executed on the crystal structure of VEGFR-2 in complex with 01-435. Pull force, van der Waals and electrostatic interaction along the two paths were calculated by using SMD simulation. The SMD simulation results indicate that the more favorable path for inhibitor dissociation is along with the traditional ATP-channel rather than the allosteric-pocket-channel, which is mainly due to the less electrostatic interaction that the ligand suffers during dissociation process along the traditional ATP-channel.

Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (326 K)Download as PowerPoint slide